Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (3001)	6/30/2010 1:08:54 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

DXCM is trying to make a 3Yrs. H in spite of the general market doldrums.<g> The stock is up 5.77% on volume about 2/3 its ADV bigcharts.marketwatch.com It traded above the $12 making another 52wks H and it needs to go above $12.15, its Dec.06 H to make a 3Yrs.H <g> DXCM has 4Qs of better revenues and has continued to trim its losses.<g> Last week it announced some changes on its Board of Directors,with Jorge Valdes, a graduate of the Univ. of Miami, now its Chief Technical Officer.<g> There is no ACTAY The stock remains very speculative, but with some good news it could get to the $15 level.<g> bigcharts.marketwatch.com Bernard